Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.37B |
| 4 |
Linde
LIN
|
+$756M |
| 5 |
DuPont de Nemours
DD
|
+$595M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.51B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$315M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$314M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
PPLI
People Inc
PPLI
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.07% |
| 2 | Financials | 6.12% |
| 3 | Healthcare | 5.17% |
| 4 | Consumer Discretionary | 4.88% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
CytomX Therapeutics
CTMX
$728M
| $197K | ﹤0.01% |
29,540
-5,122
| -15% | -$38K |
|
3802
Culp Inc
CULP
$43.8M
| $197K | ﹤0.01% |
15,900
-4,306
| -21% | -$48.3K |
|
3803
CEL-SCI Corp
CVM
$26.7M
| $197K | ﹤0.01% |
516
-2,561
| -83% | -$1.01M |
|
3804
Horizon Bancorp
HBNC
$1.06B
| $197K | ﹤0.01% |
19,611
-3,986
| -17% | -$41.4K |
|
3805
CALL
Lincoln National
LNC
$8.75B
| $197K | ﹤0.01% |
6,300
-1,600
| -20% | -$57.1K |
|
3806
Mercer International
MERC
$31.9M
| $197K | ﹤0.01% |
29,900
+15,460
| +107% | +$118K |
|
3807
Movado Group
MOV
$798M
| $197K | ﹤0.01% |
19,734
+4,700
| +31% | +$50.3K |
|
3808
PUT
MPLX
MPLX
$60B
| $197K | ﹤0.01% |
12,500
| – | – |
|
3809
CALL
Deutsche Bank
DB
$72.4B
| $196K | ﹤0.01% |
23,300
| – | – |
|
3810
PUT
Enbridge
ENB
$111B
| $196K | ﹤0.01% |
6,700
| – | – |
|
3811
PUT
Herbalife
HLF
$1.29B
| $196K | ﹤0.01% |
4,200
-3,000
| -42% | -$147K |
|
|
ITIC
3812
Investors Title Co
ITIC
$537M
| $196K | ﹤0.01% |
1,505
-47
| -3% | -$6.05K |
|
3813
Kirby Corp
KEX
$7.3B
| $196K | ﹤0.01% |
5,422
-2,026
| -27% | -$89.3K |
|
3814
PUT
Kinross Gold
KGC
$32.3B
| $196K | ﹤0.01% |
22,200
-7,100
| -24% | -$61.4K |
|
3815
PUT
Ross Stores
ROST
$78.4B
| $196K | ﹤0.01% |
2,100
| – | – |
|
3816
Syndax Pharmaceuticals
SNDX
$1.72B
| $196K | ﹤0.01% |
13,244
-36,404
| -73% | -$555K |
|
3817
Telephone and Data Systems
TDS
$4.03B
| $196K | ﹤0.01% |
10,650
-9,619
| -47% | -$202K |
|
3818
CALL
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.11B
| $196K | ﹤0.01% |
490
| – | – |
|
3819
Valvoline
VVV
$4.34B
| $196K | ﹤0.01% |
10,334
-36,159
| -78% | -$747K |
|
3820
MannKind Corp
MNKD
$1.23B
| $195K | ﹤0.01% |
103,502
-17,965
| -15% | -$31.1K |
|
|
CNCE
3821
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $195K | ﹤0.01% |
19,833
+4,088
| +26% | +$40.3K |
|
3822
PUT
iShares MSCI Turkey ETF
TUR
$221M
| $194K | ﹤0.01% |
9,800
| – | – |
|
|
YELL
3823
DELISTED
Yellow Corporation Common Stock
YELL
| $194K | ﹤0.01% |
49,500
-10,306
| -17% | -$37.7K |
|
|
VRTV
3824
DELISTED
VERITIV CORPORATION
VRTV
| $193K | ﹤0.01% |
15,277
+1,914
| +14% | +$30.7K |
|
3825
Spectrum Brands
SPB
$2.06B
| $192K | ﹤0.01% |
3,362
+1,554
| +86% | +$85.2K |
|
Similar funds
Barclays's Q3 2020 Portfolio in Review
As of Q3 2020, Barclays held 5,906 positions worth $168B, up 30% from $129B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays deployed $26.3B of net new capital in Q3 2020, opening 241 new positions and adding to 1,886 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 9.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $1.51B trimmed.
- Barclays's largest Q3 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
- Barclays added most to Visa in Q3 2020, an estimated $2.17B increase.
- Barclays's biggest Q3 2020 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $1.51B.
- Barclays fully exited People Inc in Q3 2020, selling an estimated $239M.
- Barclays's ten largest holdings make up 34% of its $168B portfolio in Q3 2020.
- Barclays opened 241 new positions and closed 676 in Q3 2020.
- Barclays's portfolio value rose 30% quarter-over-quarter to $168B.
Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.